Teligent, Inc. does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by ...

During Q2, Teligent (NASDAQ: TLGT) brought in sales totaling $13.59 million. However, earnings decreased 75.81%, resulting in a loss of $4.37 million. In Q1, Teligent brought in $7.45 million in sales ...

Add Yahoo as a preferred source to see more of our stories on Google. BUENA VISTA – A medical supply firm has purchased the former home of Teligent Inc. here. Denver-based Leiters plans to begin ...

Shares of specialty generic pharmaceutical manufacturer Teligent (NASDAQ: TLGT) dropped as much as 46% today after investors digested the company's third-quarter 2017 results. Operations appeared to ...

(Reuters) - Generic drugmaker Teligent Inc filed for bankruptcy protection on Thursday with plans to sell itself, citing "regulatory and legal setbacks" including a warning letter from the U.S. Food ...

Hikma, a London-based generics maker, paid $45.75 million to snap up the Canadian assets of Teligent, which filed for bankruptcy last October. The deal, which is expected to close by the end of the ...

Shares tumbled despite the company reporting two positive developments during the month. With such a big hit to the share price, you might assume that something bad happened at the company, but in ...

The main bidder for Teligent Inc., IDT Corp., backed out of a deal to purchase the bankrupt wireless telecommunications company yesterday, leaving Teligent's future as a company in doubt, according to ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...

First Avenue Networks, a wireless spectrum leasing company, agreed to pay about $105 million in stock for the assets of Teligent Inc., a Herndon company that was considered one of the area's rising ...

For the second time in just over six weeks, Teligent Pharma recalled Lidocaine HCl Topical Solution 4%, 50ml for super potency. This time, instead of just one lot, Teligent pulled five lots, four ...

Shares of specialty generic pharmaceutical manufacturer Teligent (TLGT +0.00%) dropped as much as 46% today after investors digested the company's third-quarter 2017 results. Operations appeared to ...